GTH logo

GTH Stock

Profile

Full Name:

Genetron Holdings Limited

Sector:

Healthcare

Industry:

Diagnostics & Research

Country:

China

IPO:

15 June 2020

Indexes:

Not included

Website:

http://www.genetronhealth.com

Description:

Genetron Holdings Limited, a precision oncology platform company, focuses on cancer management by utilizing technologies in molecular biology and data science in the People's Republic of China. It offers diagnosis and monitoring services, and early screening services through laboratory developed tests services. The company also provides in-vitro diagnostic products, including 8-gene lung cancer assay, an IVD assay product to detect lung cancer; Genetron 3D biochip reading instrument; Genetron S5, a semiconductor-based NGS system, which detects the nucleotide through detecting the change in pH; Genetron Chef System; Genetron S2000 platform, a production-scale sequencer; and Onco PanScan, a genomic profiling service for various solid tumors. In addition, it offers IDH1 and TERT gene assays for glioma; thyroid basic assay for thyroid tumor; platelet-derived growth factor receptor alpha assay for GIST cancer; and HCCscan, a qPCR-based assay to detect hepatocellular carcinoma. Further, it provides development services in the areas of genomics research and clinical development in collaboration with biopharmaceutical companies worldwide. Genetron Holdings Limited was founded in 2013 and is headquartered in Beijing, the People's Republic of China.

Key Details

Price

-

Market Cap

-

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$96.87 M(+17.58% YoY)

Annual EPS

-$3.89(-54.87% YoY)

PE Ratio

-

Annual ROE

-89.37%

Annual Debt To Equity

0.21

Beta

-

Events Calendar

Earnings

Next earnings date:

N/A

Recent quarterly earnings:

May 31, 2024

Recent annual earnings:

Mar 29, 2022
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Oct 26, 2023

Analyst ratings

Recent major analysts updates

21 Apr '22 BTIG
Buy
14 July '20 Canaccord Genuity
Buy
14 July '20 BTIG
Buy

Screeners with GTH included

No data

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price All-time High

$91.92
GTH price is currently at an all-time high

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Revenue 3-Year Change

+106.89%
GTH annual revenue is up +106.89% over the past 3 years

Annual Revenue Estimate

$105.21 M
GTH annual revenue is currently -7.92% lower than the consensus analysts' forecast

Annual Net Income 3-Year Change

-22.97%
GTH annual net profit is down -22.97% over the past 3 years

Annual EPS 3-Year Change

+8.59%
GTH annual earnings per share is up +8.59% over the past 3 years

Annual Gross Profit

$41.90 M
GTH annual gross profit is $41.90 million

Annual Operating Profit

-$94.03 M
GTH annual operaing income is -$94.03 million

Annual Operating Profit 3-Year Change

-112.44%
GTH annual operaing income is down -112.44% over the past 3 years

Efficiency

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual ROE

-89.37%
GTH annual return on equity is -89.37%

Annual ROA

-63.43%
GTH annual return on assets is -63.43%

Annual EBIT

-$104.09 M
GTH annual earnings before interest & taxes is -$104.09 million

Annual EBITDA

-$92.56 M
GTH annual earnings before interest, taxes, depreciation & amortization is -$92.56 million

Annual Interest Coverage Ratio

-6.27
GTH annual interest coverage ratio is -6.27

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Quick Ratio

1.71
GTH annual quick ratio is 1.71

Annual Current Ratio

1.82
GTH annual current ratio is 1.82

Annual Total Assets

$141.37 M
GTH annual total assets is $141.37 million

Annual Current Assets

$102.76 M
GTH annual total current assets is $102.76 million

Annual Total Liabilities

$61.89 M
GTH annual total liabilities is $61.89 million

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual CFO 3-Year Change

-140.27%
GTH annual cash flow from operations is down -140.27% over the past 3 years

Annual CFI 3-Year Change

+6.7%
GTH annual cash flow from investing activities is up +6.7% over the past 3 years

Annual CFF 3-Year Change

-80.26%
GTH annual cash flow from financing activities is down -80.26% over the past 3 years

Annual CAPEX

$12.23 M
GTH annual capital expenditures is $12.23 million

Annual CAPEX 3-Year Change

+230.15%
GTH annual capital expenditures is up +230.15% over the past 3 years

Annual FCF

-$80.74 M
GTH annual free cash flow is -$80.74 million

Annual FCF 3-Year Change

-150.61%
GTH annual free cash flow is down -150.61% over the past 3 years

Institutional Ownership

Similar stocks

Genetron stock rallies on CEO-led deal to go private
Genetron stock rallies on CEO-led deal to go private
Genetron stock rallies on CEO-led deal to go private
GTH
Proactive Investors12 October 2023

Genetron Holdings has announced it will go private through an acquisition by a group of investors led by its co-founder and CEO Sizhen Wang and CICC Healthcare Investment Fund which values the Chinese precision oncology platform at US$126 million. The company's US-listed American Depository Shares (ADSs) jumped 27% in early Thursday trading to $1.1950.

FAQ

  • What is the primary business of Genetron Holdings Limited?
  • What is the ticker symbol for Genetron Holdings Limited?
  • Does Genetron Holdings Limited pay dividends?
  • What sector is Genetron Holdings Limited in?
  • What industry is Genetron Holdings Limited in?
  • What country is Genetron Holdings Limited based in?
  • When did Genetron Holdings Limited go public?
  • Is Genetron Holdings Limited in the S&P 500?
  • Is Genetron Holdings Limited in the NASDAQ 100?
  • Is Genetron Holdings Limited in the Dow Jones?
  • When was Genetron Holdings Limited's last earnings report?
  • When does Genetron Holdings Limited report earnings?

What is the primary business of Genetron Holdings Limited?

Genetron Holdings Limited, a precision oncology platform company, focuses on cancer management by utilizing technologies in molecular biology and data science in the People's Republic of China. It offers diagnosis and monitoring services, and early screening services through laboratory developed tests services. The company also provides in-vitro diagnostic products, including 8-gene lung cancer assay, an IVD assay product to detect lung cancer; Genetron 3D biochip reading instrument; Genetron S5, a semiconductor-based NGS system, which detects the nucleotide through detecting the change in pH; Genetron Chef System; Genetron S2000 platform, a production-scale sequencer; and Onco PanScan, a genomic profiling service for various solid tumors. In addition, it offers IDH1 and TERT gene assays for glioma; thyroid basic assay for thyroid tumor; platelet-derived growth factor receptor alpha assay for GIST cancer; and HCCscan, a qPCR-based assay to detect hepatocellular carcinoma. Further, it provides development services in the areas of genomics research and clinical development in collaboration with biopharmaceutical companies worldwide. Genetron Holdings Limited was founded in 2013 and is headquartered in Beijing, the People's Republic of China.

What is the ticker symbol for Genetron Holdings Limited?

The ticker symbol for Genetron Holdings Limited is NASDAQ:GTH

Does Genetron Holdings Limited pay dividends?

No, Genetron Holdings Limited does not pay dividends

What sector is Genetron Holdings Limited in?

Genetron Holdings Limited is in the Healthcare sector

What industry is Genetron Holdings Limited in?

Genetron Holdings Limited is in the Diagnostics & Research industry

What country is Genetron Holdings Limited based in?

Genetron Holdings Limited is headquartered in China

When did Genetron Holdings Limited go public?

Genetron Holdings Limited's initial public offering (IPO) was on 15 June 2020

Is Genetron Holdings Limited in the S&P 500?

No, Genetron Holdings Limited is not included in the S&P 500 index

Is Genetron Holdings Limited in the NASDAQ 100?

No, Genetron Holdings Limited is not included in the NASDAQ 100 index

Is Genetron Holdings Limited in the Dow Jones?

No, Genetron Holdings Limited is not included in the Dow Jones index

When was Genetron Holdings Limited's last earnings report?

Genetron Holdings Limited's most recent earnings report was on 31 May 2024

When does Genetron Holdings Limited report earnings?

The date for Genetron Holdings Limited's next earnings report has not been announced yet